Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THDB0206 vs Humalog in Type 1 Diabetes (Phase 3, China)
CTR20220042Phase 3Completed
- Sponsor
- Tonghua Dongbao
- Start
- Jan 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of BioChaperone Lispro in diabetes mellitus type 1 (T1D), sponsored by Tonghua Dongbao. Started Jan 2022; status: completed.
02
Drugs
BioChaperone Lispro
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on CTR20220042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220042.